Integrin Cross Talk: Activation of Lymphocyte Function-associated  Antigen-1 on Human T Cells Alters α4β1- and α5β1-mediated Function by Porter, Joanna C. & Hogg, Nancy
 
ã
 
 The Rockefeller University Press, 0021-9525/97/09/1437/11 $2.00
The Journal of Cell Biology, Volume 138, Number 6, September 22, 1997 1437–1447
http://www.jcb.org 1437
 
Integrin Cross Talk: Activation of Lymphocyte Function-associated 
 
Antigen-1 on Human T Cells Alters 
 
a
 
4
 
b
 
1- and 
 
a
 
5
 
b
 
1-mediated Function
 
Joanna C. Porter and Nancy Hogg
 
Leukocyte Adhesion Laboratory, Imperial Cancer Research Fund, Lincoln’s Inn Fields, London WC2A 3PX, United Kingdom
 
Abstract. 
 
A regulated order of adhesion events directs 
leukocytes from the vascular compartment into injured 
tissues in response to inflammatory stimuli. We show 
 
that on human T cells, the interaction of the 
 
b
 
2 integrin 
leucocyte function–associated antigen-1 (LFA-1) with 
its ligand intercellular adhesion molecule-1 (ICAM-1) 
will decrease adhesion mediated by 
 
a
 
4
 
b
 
1 and, to a 
lesser extent, 
 
a
 
5
 
b
 
1. Similar inhibition is also seen when 
T cells are exposed to mAb 24, which stabilizes LFA-1 
in an active state after triggering integrin function 
 
through divalent cation Mg
 
2
 
1
 
, PdBu, or T cell receptor/
CD3 complex (TCR/CD3) cross-linking. Such cross 
talk decreases 
 
a
 
4
 
b
 
1 integrin–mediated binding of T 
cells to fibronectin and vascular cell adhesion molecule-1 
(VCAM-1). In contrast, ligand occupancy or prolonged 
activation of 
 
b
 
1 integrin has no effect on LFA-1 adhe-
sion to ICAM-1. We also show that T cell migration 
across fibronectin, unlike adhesion, is mediated solely 
by 
 
a
 
5
 
b
 
1, and is increased when the 
 
a
 
4
 
b
 
1-mediated 
component of fibronectin adhesion is decreased either 
by cross talk or the use of 
 
a
 
4-blocking mAb. The ability 
of mAb 24 Fab
 
9
 
 fragments to induce cross talk without 
cross-linking LFA-1 suggests signal transduction 
through the active integrin. These data provide the first 
direct evidence for cross talk between LFA-1 and 
 
b
 
1 in-
tegrins on T cells. Together, these findings imply that 
activation of LFA-1 on the extravasating T cell will de-
crease the binding to VCAM-1 while enhancing the 
subsequent migration on fibronectin. This sequence of 
events provides a further level of complexity to the co-
ordination of T cell integrins, whose sequential but 
overlapping roles are essential for transmigration.
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1. 
 
Abbreviations used in this paper
 
: ICAM-1, intercellular adhesion mole-
cule-1; LFA-1, lymphocyte function–associated antigen-1; PdBu, phorbol-
12,13-dibutyrate; TCR/CD3, T cell receptor/CD3 complex; VCAM-1, vas-
cular cell adhesion molecule-1.
 
T
 
he 
 
regulation of lymphocyte extravasation from the
circulation into sites of inflammation is critical in
coordinating an appropriate and effective immune
response. There is careful control not only of the particu-
lar tissues into which migration occurs, but also of the var-
ious subtypes of leukocytes involved (Butcher and Picker,
1996). Under flow conditions, circulating lymphocytes can
attach and roll on vascular endothelium using the selectins
and 
 
a
 
4 integrins (Alon et al., 1995; Berlin et al., 1995; Lus-
cinskas et al., 1995). These adhesion receptors are able to
slow the transit of leukocytes and expose them to stimuli
causing activation-dependent firm adhesion. The integrins
 
a
 
4
 
b
 
1, 
 
a
 
4
 
b
 
7, and leukocyte function–associated antigen-1
(LFA-1)
 
1
 
 have been implicated in activation-dependent
stable arrest of lymphocytes under flow (Bargatze et al.,
1995). LFA-1, however, unlike the 
 
a
 
4 integrins, cannot ini-
tiate adhesion under these conditions without L-selectin
and/or 
 
a
 
4
 
b
 
7 first tethering the lymphocyte to the vessel
wall (Bargatze et al., 1995). Subsequently, LFA-1 is the
principal integrin involved in transendothelial migration
(van Epps et al., 1989; Smith et al., 1989; Oppenheimer-
Marks et al., 1991), although the stimulus that induces this
 
b
 
2 integrin–dependent movement across the endothelial
layer is unclear. Interaction with and migration across fi-
bronectin and other extracellular matrix components are
then necessary for the successful completion of migration
into the tissues. Therefore, transmigration of any one T
cell is a multistep process dependent on the tight regula-
tion of the sequential and often overlapping activities of
the expressed integrins (Bargatze et al., 1995).
There is increasing evidence that, on a given cell, one
subset of integrins may be negatively regulated by ligation
of another. Transfection of 
 
a
 
v
 
b
 
3 into K562 cells that en-
dogenously express 
 
a
 
5
 
b
 
1 provides a system in which liga-
tion of 
 
b
 
3 inhibits the phagocytic but not adhesive func-
tion of 
 
a
 
5
 
b
 
1 (Blystone et al., 1994). Similarly, ligation of
transfected 
 
a
 
IIb
 
b
 
3 will inhibit the function of cotrans-
fected 
 
a
 
2
 
b
 
1 or endogenous 
 
a
 
5
 
b
 
1 in CHO cells expressing
these integrins (Diáz-González et al, 1996). Such effects
are dependent on an intact 
 
b
 
3 cytoplasmic tail, and are
considered to involve signal transduction (Blystone et al.,
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1995; Diáz-González et al., 1996). In a further example,
ligand-binding by 
 
a
 
4
 
b
 
1 on fibroblasts was able to suppress
the ability of 
 
a
 
5
 
b
 
1 to induce metalloproteinase expression
(Huhtala et al., 1995).
There is also indirect evidence of similar integrin regula-
tion on T cells. For example, resting lymphocytes use both
LFA-1 and 
 
a
 
4
 
b
 
1 to bind endothelial cells, but when T cells
become activated, adhesion is mediated through LFA-1
with little or no contribution from 
 
a
 
4
 
b
 
1 (van Kooyk et al.,
1993). Additionally, in some leukemic T cell lines, func-
tional 
 
a
 
4
 
b
 
1 is found only when LFA-1 is either not ex-
pressed or inactive (van Kooyk et al., 1993). Therefore,
there appears to be a T cell integrin hierarchy in which
 
a
 
4
 
b
 
1 is inactive if LFA-1 is active. Here we provide direct
evidence of cross talk on T cells between 
 
b
 
2 and 
 
b
 
1 integ-
rins. The avid state of the 
 
b
 
2 integrin, LFA-1, can be main-
tained by the ligand intercellular adhesion molecule-1
(ICAM-1) or by activation mAbs. Such sustained activa-
tion of LFA-1 is shown to downregulate the adhesion
through 
 
a
 
4
 
b
 
1 and, to a lesser extent, through 
 
a
 
5
 
b
 
1 to the
ligands fibronectin and vascular cell adhesion molecule-1
(VCAM-1) (
 
a
 
4
 
b
 
1 alone). The result, phenotypically, is a
less adhesive, more migratory T cell. Therefore, we have
demonstrated another way in which integrin activities may
be regulated.
 
Materials and Methods
 
Preparation of T Lymphoblasts
 
Peripheral blood mononuclear cells were prepared from single donor leu-
kocyte buffy coats by centrifugation through Lymphoprep
 
®
 
 (Pharmacia
Diagnostics AB, Uppsala, Sweden). T cells were expanded from this pop-
ulation by culturing in RPMI 1640 plus 10% FCS (GIBCO BRL, Paisley,
UK) in the presence of phytohaemagglutinin (Murex Diagnostics, Dart-
ford, UK) at 1 
 
m
 
g/ml for 72 h as previously described (Dransfield et al.,
1992
 
a
 
). Cells were then washed and maintained for 1–2 wk in medium
supplemented with 20 ng/ml recombinant IL-2 (Euro Cetus UK Ltd.,
Harefield, UK). The cells, which were used between days 10 and 14, were
a 99% CD3
 
1
 
 population, containing 65% CD8
 
1
 
 and 35% CD4
 
1
 
 cells. The
population was negative for the natural killer cell marker CD56.
 
mAbs and Other Reagents
 
mAb 925.2 (CD11a; LFA-1
 
a
 
 subunit, nonblocking) was purchased from
Becton Dickinson (Oxford, UK). mAbs 38 (CD11a; LFA-1 
 
a
 
 subunit
function–blocking), and 24 (CD11/CD18; 
 
b
 
2 integrin activation reporter)
(Dransfield et al., 1992
 
b
 
; Dransfield and Hogg, 1989) and 52U (control an-
tibody) were prepared in this laboratory, and purified from ascites or tis-
sue culture supernatant by protein A–Sepharose chromatography (Ey et
al., 1978). mAbs HP1/2 (CD49d; 
 
a
 
4 subunit function–blocking) and TS2/
16 (CD29; 
 
b
 
1 subunit-activating) were gifts from R. Lobb (Biogen, Inc.,
Cambridge, MA). mAb SAM-1 (CD49e; 
 
a
 
5 subunit–blocking) was pur-
chased from Eurogenetics (Hampton, UK). mAb 7.2 (CD49d; 
 
a
 
4 subunit,
nonblocking) was a gift from J. Marshall (Imperial Cancer Research
Fund, London, UK). mAb UCHT2 (CD5) was a gift from P. Beverley
(University College, London, UK). mAb G19.4 was a gift from Bristol My-
ers-Squibb Pharmaceuticals (Princeton, NJ). Rabbit anti–mouse IgG was
purchased from Sigma Chemical Co. (Poole, UK).
ICAM-1Fc was produced as a chimeric protein, consisting of the five
extracellular domains of ICAM-1 fused to the Fc fragment of human IgG1
(Berendt et al., 1992). VCAM-1Fc, produced as a chimera consisting of
the two amino-terminal domains of human VCAM-1 fused to the Fc frag-
ment of human IgG1 (Jakubowski et al., 1995), was a gift from R. Lobb.
Fibronectin (0.1% solution from human plasma) was purchased from
Sigma Chemical Co., and cytochalasin D from GIBCO BRL. The fluorescent
cell label 2
 
9
 
,7
 
9
 
-bis-([carboxyethyl]-5[6
 
9
 
]-carboxyfluorescein) (BCECF-AM)
was purchased from Calbiochem Corp. (Nottingham, UK). All other
chemicals and reagents were purchased from Sigma Chemical Co.
 
Ligand-coated Beads
 
A modified protocol (Pyszniak et al., 1994) was developed in which 200 
 
m
 
l
(10
 
8
 
) of 3.2-
 
m
 
m polystyrene beads (Sigma Chemical Co.) were washed
twice in distilled water, followed by two further washes and resuspension
in 0.1 M bicarbonate buffer, pH 9. Fibronectin, ICAM-1, VCAM-1, or
BSA as control were added to these beads to a final concentration of 10
 
m
 
g/ml. The beads were rotated at room temperature for 1 h, washed once
in PBS, and blocked with 0.1% denatured BSA for 2 h at room tempera-
ture while being rotated. The beads were then washed twice in 20 mM
Hepes, 140 mM NaCl, 2 mg/ml glucose, pH 7.4 (assay buffer), containing 3
mM Mg
 
2
 
1
 
/2 mM EGTA, for use in the adhesion experiments as described.
 
Cell Bead Attachment Assay
 
Multiwell Lab-Tek
 
®
 
 Chamber Slides (Nunc, Inc., Naperville, IL) were left
uncoated as controls or coated with either ICAM-1Fc (10 
 
m
 
g/ml in PBS)
or rabbit anti–mouse Ig (1:100 dilution in PBS) overnight at 4
 
8
 
C. The next
day, mAb tissue culture supernatant was added to wells precoated with
anti–mouse Ig and left on ice for 1 h. Wells were washed twice with PBS,
and nonspecific binding sites were blocked with 0.1% denatured BSA for
2 h at room temperature. Cells (150 
 
m
 
l of 2 
 
3
 
 10
 
6
 
/ml) in assay buffer (see
above) containing 3 mM Mg
 
2
 
1
 
/2 mM EGTA were added to the wells and
allowed to settle on ice for 15 min. Freshly prepared ligand-coated beads
(see above) were added to the wells at 100:1 bead-to-cell ratio in 50 
 
m
 
l. Af-
ter 30 min at 37
 
8
 
C, the unbound beads and cells were removed with four
washes in warmed assay buffer. Bound cells were fixed with 1% formalde-
hyde in PBS for 20 min at room temperature. Cells were then stained with
haematoxylin for 10 min. Beads and cells were counted per high power
field (
 
3
 
40 oil immersion objective; Carl Zeiss, Inc., Thornwood, NY), and
the number of beads per 100 cells was determined (attachment index).
 
Cell Attachment Assays
 
Flat-bottomed Immulon-1
 
®
 
 96-well plates (Dynatech Labs., Inc., Chan-
tilly, VA) were precoated with 50 
 
m
 
l fibronectin (20 
 
m
 
g/ml), VCAM-1Fc
(7 
 
m
 
g/ml), or ICAM-1Fc (2.4 
 
m
 
g/ml) in PBS overnight at 4
 
8
 
C. The plates
were blocked with 2.5% BSA in PBS for 2 h at room temperature and
then washed four times in assay buffer (see above) at 4
 
8
 
C. T cells were
washed three times in assay buffer and labeled with 2.5 
 
m
 
M BCECF-AM
in the same buffer for 30 min at 37
 
8
 
C, followed by two further washes. T
cells (2 
 
3
 
 10
 
5
 
 cells) were treated with 3 mM Mg
 
2
 
1/2 mM EGTA, 50 nM
phorbol-12,13-dibutyrate (PdBu), or CD3 mAb at indicated levels, as well
as inhibitors and mAbs in 100 ml assay buffer. Ca21 and Mg21 were in-
cluded at 0.4 mM for experiments involving PdBu or T cell receptor/CD3
complex (TCR/CD3) cross-linking with mAb G19.4. Blocking mAbs were
titrated on T cells by FACS® analysis (Becton Dickinson, Mountain View,
CA) and used at saturating concentrations to block T cell function. For fi-
bronectin- and VCAM-1–binding assays, all wells contained anti–LFA-1
mAb 38 at function-blocking concentrations of 10 mg/ml. This prevents
cells aggregating via LFA-1/ICAM-1 interactions, which would cause spuri-
ously high binding to b1 ligands through the piggy-back interaction of
nonadherent cells with truly adherent cells. Plates were incubated for 15
min on ice, followed by centrifugation at 40 g for 1 min, before 40-min in-
cubation at 378C. Nonadherent cells were removed by washing four times
in warmed assay buffer (150 ml/well). Adhesion was quantified by recording
emission at 530 nm, after excitation at 485 nm, using a Fluoroskan® II
(Labsystems, Inc., Basingstoke, UK), and by expressing the reading for
each well as a percentage of the total emission before incubation.
Transmigration Assays
Assays were performed in 20 mM Hepes, 140 mM NaCl, 2 mg/ml glucose,
pH 7.4, 0.25% BSA, 3 mM Mg21/2 mM EGTA (transmigration buffer) us-
ing 6.5-mm-diam Transwell® plates (Costar Corp., Cambridge, MA). The
upper and lower surfaces of the inserts were coated with fibronectin at
concentrations ranging from 0 to 50 mg/ml in PBS overnight at 48C. The
inserts were positioned in wells containing 600 ml transmigration buffer.
Cells were then plated in the insert at a concentration of 5 3 105 cells in
100 ml transmigration buffer with appropriate mAbs. The mAbs were
used at the following final concentrations: mAb HP1/2 at 0.7 mg/ml, mAb
7.2 at 5 mg/ml, mAb SAM-1 at 5 mg/ml, mAb 24 at 5 mg/ml, and mAb 52U
at 5 mg/ml. The anti–LFA-1 mAb 38 was added to all inserts at function-
blocking concentrations of 10 mg/ml to prevent a spurious decrease in mi-
gration due to cell aggregation when LFA-1 is activated. The plates were
then incubated for 6 h at 378C. The bottom surface of the insert was thenPorter and Hogg Cross Talk between LFA-1 and b1 Integrins 1439
scraped to release migrated but adherent cells into the bottom well, and
the migrated cells were counted in a hemocytometer. Nine grids (0.1 mm3
per grid) were counted per well, and readings were averaged from dupli-
cate samples. All assays were performed in duplicate, and each experi-
ment was repeated a minimum of four times.
Results
In this study, we have investigated cross influences on
function between the b1 integrins and LFA-1 on T cells.
As one method of activating these leukocyte integrins, we
treated T cells with 3 mM Mg21/2 mM EGTA (Dransfield
et al., 1992a). For the b2 integrin, LFA-1, the advantage
of such treatment is that it directly alters the integrin
ectodomain, bypassing the requirement for an intracellu-
lar stimulus (Stewart et al., 1996). This form of LFA-1 is
considered to be of high affinity because it is able to bind
soluble ICAM-1 (Stewart et al., 1996). There have been
both positive and negative reports of the ability of Mg21/
EGTA to induce fibronectin receptor–mediated adhesion
(Shimizu and Mobley, 1993; Luque et al., 1996). In this
study, we show that T cells do bind fibronectin, immobi-
lized either on plates or on beads, in an Mg21-dependent
manner. To examine further the generality of cross-influ-
ences between these integrins, we also investigated T cells
stimulated with phorbol ester or by TCR/CD3 cross-link-
ing. Both of these stimuli act from within the cell to acti-
vate integrins, so called inside-out signaling, and may be
considered more representative of the in vivo situation.
Adhesion of T Cells to ICAM-1 Will Decrease Binding 
of Fibronectin-coated Beads
To determine the effect of LFA-1 ligation on the function
of the b1 integrins on the same T cell, we developed a
ligand-coated bead–binding system. T cells were adhered
to immobilized ICAM-1 via LFA-1, or to a control sub-
strate, and their ability to bind beads coated with ligand
for the b1 integrins, a4b1 and a5b1, was then investigated.
Fibronectin-coated beads were bound by T cells adherent
to the control substrate, anti-CD5 mAb, immobilized on
plastic (Fig. 1 A), and the specificity of adhesion was dem-
onstrated by blocking bead-binding with a combination of
a4 and a5 mAbs (Fig. 1 B). However, when T cells were
adherent to ICAM-1 as substrate, they bound fewer fi-
bronectin-coated beads (Fig. 1 C). When binding of the fi-
bronectin-coated beads was quantified, there was a de-
creased level of fibronectin bead-binding when T cells
were adherent to ICAM-1 (Fig. 2 A) (inhibition: 65.0 6
23.4% 5 mean 6 SD; n 5 6). This result demonstrated
that, on human T cells, the interaction of LFA-1 with its
ligand ICAM-1 could downregulate the function of the b1
integrins. In contrast, T cells adhered to anti–LFA-1 mAb
bound beads at a similar level as T cells adherent to con-
trol mAb. This indicated that the LFA-1 inhibitory effect
could not be mimicked by cross-linking LFA-1 with immo-
bilized CD11a mAb 38 (Fig. 2 A). Conversely, there was
no difference between the ability of T cells adherent to
anti-CD5 mAb, fibronectin, or ICAM-1 to bind ICAM-1–
coated beads (Fig. 2 B), indicating that adhesion to immo-
bilized fibronectin did not alter the extent of ICAM-1
bead binding by LFA-1. This is the first evidence that
LFA-1 could dominate the activity of the fibronectin-bind-
ing receptors and that the reverse situation did not hold.
Adhesion of T Cells to ICAM-1 Decreases
Binding of Fibronectin- and VCAM-1–coated Beads
by Downregulating a4b1 Activity
We then looked at the effects of LFA-1 ligand–binding on
each of the T cell fibronectin receptors, a4b1 and a5b1.
Both of these integrins can be involved in T cell binding to
fibronectin, and, if one is blocked, the other can partially
Figure 1. Fibronectin bead–binding is reduced when T cells ad-
here to ICAM-1. Cultured human T cells treated with 3 mM
Mg21/2 mM EGTA and adhered to plastic coated with anti-CD5
(mAb UCHT2) (A and B) and ICAM-1 (C) were incubated with
fibronectin-coated beads. Bead-binding was blocked using a com-
bination of the a4 and a5 function–blocking mAbs HP1/2 (0.5 mg/
ml) and SAM-1 (0.5 mg/ml) (B). Bar, 20 mm.The Journal of Cell Biology, Volume 138, 1997 1440
compensate, as previously described (Wayner et al., 1989).
Fig. 3 A shows the binding of fibronectin-coated beads by
T cells adherent to anti-CD5 mAb. This binding can be
partially blocked with either an a4-blocking mAb, an a5-
blocking mAb, or completely with a combination of both
blocking mAbs, showing that T cells bind these beads
through a mixture of a4b1 and a5b1 integrins. However,
when T cells are adherent to ICAM-1, the binding index
for fibronectin-coated beads is lower, and is reduced only
by an a5-blocking mAb (Fig. 3 B). Therefore, binding in
this situation is mediated mainly through a5b1 with little
contribution from a4b1, demonstrating that the binding
activity of a4b1 has been compromised. The binding by T
cells of VCAM-1–coated beads, which is mediated exclu-
sively by a4b1, reveals a similar downregulation when T
cells are adherent to ICAM-1 as compared to anti–LFA-1
mAb (Fig. 4).
Activation of the b2 Integrin LFA-1 on T Cells Inhibits 
Their b1-Mediated Binding to Fibronectin
The inhibitory effect of LFA-1 on b1-mediated ligand-
binding could not be demonstrated by cross-linking LFA-1
with an anti–LFA-1 mAb, but required binding to ligand
ICAM-1. This suggested that high affinity LFA-1 rather
than receptor cross-linking was necessary for cross talk.
This led to the development of an assay in which T cells
were first stimulated with Mg21/EGTA, TCR/CD3 cross-
linking, or PdBu and then exposed to mAb 24, which holds
LFA-1 in an active conformation as if occupied by ligand
(Dransfield et al., 1992b). mAb 24 caused increased T cell
binding to ICAM-1 after titration of Mg21 (Fig. 5 A), CD3
mAb G19.4 (Fig. 5 B), and PdBu (not shown). In contrast,
mAb 24 caused inhibition of T cell binding to fibronectin
after TCR/CD3 cross-linking (Fig. 6 A) or Mg21/EGTA
(data not shown). Monovalent Fab9 fragments of mAb 24
produced the same degree of inhibition as bivalent mAb
24 (data not shown). This demonstrated that activation or
ligand occupancy of LFA-1 in the absence of clustering is
sufficient to alter fibronectin-mediated adhesion. mAb
KIM185 (CD18; b2-activating) behaved similarly to mAb
24, depressing binding of T cells to fibronectin while en-
hancing adhesion to ICAM-1 (data not shown).
The Effect of LFA-1 Activation on T Cells Is Mediated 
Predominantly through a4b1
Because T cells bind to fibronectin through both a4b1 and
a5b1, we analyzed the effects of LFA-1 activation individ-
ually on these integrins using function-blocking mAbs and
either TCR/CD3 cross-linking (Fig. 6, B and C) or Mg21/
EGTA (data not shown) to stimulate adhesion. Prolonged
activation of LFA-1 with mAb 24 had only a small effect
on total fibronectin-binding (Fig. 6 A) and on a5b1-medi-
ated adhesion (Fig. 6 B), but had a much greater effect on
a4b1-mediated adhesion (Fig. 6 C). Similar levels of a4b1
inhibition by mAb 24 were seen when the integrins were
activated with PdBu or Mg21/EGTA (Fig. 7). In addition,
there was no effect of the nonfunction-altering anti–LFA-1
mAb G25.5, which again emphasized the requirement for
LFA-1 activation (Fig. 7). Under equivalent activating
conditions, mAb 24 and the b2 integrin–activating mAb
KIM185 decreased a4b1-mediated adhesion to VCAM-1
to the same extent as to fibronectin (data not shown). To-
gether, these results reinforced the findings that a4b1
function is particularly sensitive to the state of LFA-1 acti-
vation.
Activation of b1 Integrins on T Cells Has No Effect on 
LFA-1 Binding to ICAM-1
We then reversed the situation to investigate the effect on
Figure 2. Inhibition of fibronectin bead–binding when T cells ad-
here to ICAM-1. (A) Cultured human T cells treated with 3 mM
Mg21/2 mM EGTA and adhered to plastic coated with anti-CD5
(mAb UCHT2), anti–LFA-1 (mAb 38), or ICAM-1 and incu-
bated with fibronectin-coated beads (dark bars). Bead attach-
ment was blocked with a combination of a4 and a5 function–
blocking mAbs HP1/2 and SAM-1 as previously (open bars). (B)
Cultured human T cells treated with 3 mM Mg21/2 mM EGTA
and adhered to plastic coated with anti-CD5 (mAb UCHT2), fi-
bronectin, or ICAM-1 were incubated either with ICAM-1–coated
beads (stippled bars) or with BSA-coated control beads (open
bars). The bead-binding assays were performed as described in
Materials and Methods, and data are expressed as binding index
(beads bound/100 cells). Data represent the mean of six high-
power fields 6 SEM. One representative experiment of three is
shown.Porter and Hogg Cross Talk between LFA-1 and b1 Integrins 1441
b2 integrin–mediated adhesion of maintaining b1 integrins
in an active state, using the b1 integrin–stimulating mAb
TS2/16. This mAb increased binding to fibronectin after
the three activating treatments (Fig. 8 A), but had no ef-
fect on b2-mediated binding to ICAM-1 (Fig. 8 B), con-
firming that the b1 integrins were unable to influence the
ligand-binding activity of LFA-1.
Inhibition of a4b1 with Blocking mAbs or by LFA-1 
Activation Increases a5b1-Mediated Migration
The effects of LFA-1–mediated cross talk on a4b1- and
a5b1-mediated T cell migration on fibronectin were then
investigated. Using the Transwell® system, we established
that T cells undergo random migration on fibronectin us-
Figure 4. Inhibition of
VCAM-1  bead–binding when
T cells adhere to ICAM-1.
Cultured human T cells
treated with 3 mM Mg21/2
mM EGTA were adhered to
plastic coated with anti-CD5
(mAb UCHT2), anti–LFA-1
(mAb 38), or ICAM-1 and
incubated with VCAM-1–
coated beads (hatched bars).
Bead attachment was pre-
vented by the a4-blocking
mAb HP1/2 (open bars).
Data are expressed as bind-
ing index (beads bound/100
cells) and represent the mean
of six high-power fields 6
SEM. One representative ex-
periment of three is shown.
Figure 3. Fibronectin bead–binding mediated by a4b1 is differentially inhibited when T cells are adherent to ICAM-1. Cultured human
T cells treated with 3 mM Mg21/2 mM EGTA were adhered to plastic coated with anti-CD5 (mAb UCHT2) (A) or ICAM-1 (B) and in-
cubated with fibronectin-coated beads. Bead attachment was assessed in the presence or absence of the a4 and a5 function–blocking
mAb HP1/2 and SAM-1 either alone or in combination, as previously. The data are expressed as binding index (beads bound/100 cells),
and are the mean of six high-power fields 6 SEM. One representative experiment of three is shown.The Journal of Cell Biology, Volume 138, 1997 1442
Figure 5. Prolonged activation of LFA-1 by mAb 24 increases T cell adhesion to ICAM-1 induced either by Mg21 and 2 mM EGTA (A)
or by TCR/CD3 cross-linking through CD3 mAb G19.4 in the presence of Ca21 and Mg21 at 0.4 mM (B). The LFA-1 activation anti-
body, mAb 24 (s) or mAb 52U (IgG1 isotype control) (d) were used at 20 mg/ml. Specificity of adhesion was shown by block of ICAM-1
binding with mAb 38 (LFA-1–function blocking, 10 mg/ml) (m). Data represent means of triplicates 6 SD. One representative experi-
ment of three is shown.
Figure 6. Prolonged activation of LFA-1 blocks a4b1- and to a lesser extent a5b1-mediated binding to fibronectin. Adhesion to fi-
bronectin was induced by TCR/CD3 cross-linking through CD3 mAb G19.4 in the presence of Ca21 and Mg21 at 0.4 mM. (A) Adhesion
mediated by a4b1 and a5b1 together. (B) a5b1-mediated adhesion after the a4b1 component had been blocked with mAb HP1/2 (0.5
mg/ml). (C) a4b1-mediated adhesion after the a5b1 component had been blocked with mAb SAM-1 (0.5 mg/ml). Adhesion was assessed
in the presence of the LFA-1 activation antibody, mAb 24 (open symbols), or the isotype-matched control antibody, mAb 52U (closed
symbols), used at 20 mg/ml. Data represent means of triplicates 6 SD. One representative experiment of three is shown. The specificity
of the adhesion is shown by the block achieved using a4- and a5-blocking mAbs as indicated.Porter and Hogg Cross Talk between LFA-1 and b1 Integrins 1443
ing a5b1 exclusively, and that this migration was enhanced
by an a4-blocking mAb HP1/2, but not affected by an a4–
nonblocking mAb 7.2 (Fig. 9 A). In addition, migration at
different concentrations of fibronectin remained solely de-
pendent on a5b1 (Fig. 9 B), and could be enhanced either
with a4-blocking mAb HP1/2 (Fig. 9 C), or by maintaining
LFA-1 activation with mAb 24 (Fig. 9 D). Such increased
migration was blocked with an a5-blocking mAb. There-
fore, by decreasing the a4b1 contribution to fibronectin
adhesion with either an a4-blocking mAb or an LFA-1–
activation mAb, the ability of a5b1 to mediate migration
was increased.
Investigation of the Mechanism of LFA-1 Cross Talk
Treatment of T cell LFA-1 with Mg21/EGTA directly in-
duces a high affinity form of the integrin that is able to
bind soluble ICAM-1 (Stewart et al., 1996). Therefore, we
looked at the ability of b1 integrins to adopt a high affinity
state. However, treatment with Mg21/EGTA yielded no
detectable binding of soluble fibronectin or VCAM-1,
even when these ligands were used at concentrations up to
1.2 mg/ml. In contrast, 0.5 mM Mn21 was able to induce fi-
bronectin (a4b1 and a5b1)– and VCAM-1 (a4b1)–bind-
ing to both T cells and Jurkat cells (data not shown), as has
been reported by others (Jakubowski et al., 1995; Gomez
et al., 1997). Similarly, while 0.5 mM Mn21 was able to in-
duce expression of the b1 activation reporter epitopes rec-
ognized by mAb 15/7 (Yednock et al., 1995) or mAb
HUTS-21 (Luque et al., 1996), no expression of these
epitopes was observed with Mg21/EGTA treatment (data
not shown). These findings imply that the fibronectin-
binding integrins are in a low affinity state after all three
methods of stimulation, and that LFA-1 cross talk causes
inhibition of postreceptor occupancy events, rather than
direct modulation of receptor affinity.
We next tested the possibility that LFA-1 activation
might be influencing a cytoskeletal event. Although mAb
24 decreased the overall level of a4b1-mediated adhesion
to fibronectin, there was no change in the sensitivity of
binding to cytochalasin D (Fig. 10). Therefore, LFA-1
cross talk affects an event in cell adhesion after receptor
occupancy but before changes in the actin cytoskeleton,
and is independent of both.
Discussion
This study was undertaken to examine the functional in-
teraction on T cells between LFA-1 and the b1 integrin fi-
bronectin receptors a4b1 and a5b1. The main findings are
that (a) the occupation of T cell LFA-1 by its ligand
ICAM-1 decreases the binding of a4b1 to ligands fi-
bronectin and VCAM-1; (b) this inhibitory cross talk also
results from the prolonged activation of LFA-1 induced by
the activation reporter mAb 24 in combination with sev-
eral T cell adhesion–inducing protocols; (c) the adhesive
activity of a5b1 is affected to a lesser extent; (d) while ac-
tive LFA-1 downregulates the avidity of a4b1, the reverse
does not occur, as neither b1 integrin–activating mAb
TS2/16 nor b1-mediated binding to fibronectin affected
the avidity of LFA-1; and (e) downregulation of a4b1 ac-
tivity increases the efficiency of a5b1-mediated migration
on fibronectin. Therefore, we have demonstrated differen-
tial regulation of two integrin subclasses and a hierarchy of
Figure 7. Prolonged activa-
tion of LFA-1 blocks a4b1-
mediated fibronectin–bind-
ing after various stimuli.
Adhesion to fibronectin was
induced by TCR/CD3 cross-
linking using mAb G19.4 (2.5
mM) with 0.4 mM Ca21 and
Mg21 (white bars); PdBu 50
nM with 0.4 mM Ca21 and
Mg21 ( dark bars); or 3 mM
Mg21/2 mM EGTA (cross-
hatched bars). Integrin a5b1
was blocked with SAM-1 (0.5
mg/ml), allowing a4b1 adhe-
sion to be investigated in iso-
lation. Adhesion was assessed
in the presence of mAb G25.2
(an LFA-1 nonactivating and
nonblocking mAb), mAb 24,
or mAb 52U (the IgG1 iso-
type-matched control anti-
body), each used at 20 mg/ml.
Data represent means of
triplicates  6 SD. One repre-
sentative experiment of three
is shown. The specificity of
the adhesion is shown with
an  a4-blocking mAb.The Journal of Cell Biology, Volume 138, 1997 1444
integrin usage in which the b2 integrin LFA-1 will sup-
press the function of b1 integrins, particularly a4b1.
Previous studies have demonstrated the involvement of
a4b1 in leukocyte adhesion to but not migration across en-
dothelium, and of LFA-1 as the chief integrin in transen-
dothelial migration (van Epps et al., 1989; Oppenheimer-
Marks et al., 1991; Moser et al., 1992). Furthermore, in
vitro experiments during flow have emphasized the re-
quirement that an integrin hierarchy allow coordinated
migration of lymphocytes across the endothelium into the
tissues (Butcher and Picker, 1996). Our finding that active
LFA-1 is able to decrease the ligand-binding activity of
a4b1 has direct implications for the sequential activity of
these integrins in such an adhesion cascade; LFA-1 may
function optimally in the absence of a4b1 adhesion, allow-
ing the T cell to deadhere from the apical surface of the
endothelium and transmigrate. Our findings also argue
against a redundancy among integrin–ligand pairs in leu-
kocyte transmigration, and imply specific roles for each in-
tegrin.
In this study, we have demonstrated that, in contrast to
adhesion, the migration of activated T cells on fibronectin
is mediated by a5b1 with no contribution from a4b1. In
addition, suppressing a4b1 activity on T cells either by
mAb 24 or a4 function–blocking mAbs enhanced the level
of a5b1 migration, particularly at low fibronectin levels.
This may reflect the compensatory increase in a5b1 adhe-
sion, with its migratory potential, when binding through
Figure 8. b2 integrin activa-
tion decreases b1-mediated
binding of T cells, but the re-
verse is not true. T cell adhe-
sion to fibronectin (A) and
ICAM-1 (B) was induced by
TCR/CD3 cross-linking us-
ing mAb G19.4 (2.5 mg/ml)
with 0.4 mM Ca21 and Mg21,
PdBu 50 nM with 0.4 mM
Ca21 and Mg21, or 3 mM
Mg21/2 mM EGTA, and the
adhesion assay was per-
formed in the presence or ab-
sence of the b1-activating
mAb TS2/16 (10 mg/ml) or
the isotype-matched control,
mAb 52U (10 mg/ml). Speci-
ficity of adhesion was shown
by blocking of fibronectin-
binding with a combination
of  a4- and a5-blocking
mAbs, and ICAM-1–binding
with the LFA-1–blocking an-
tibody, mAb 38. Adherent
cells are expressed as per-
centage of total cells added,
and data represent means of
triplicates 6 SD. One repre-
sentative experiment of three
is shown.Porter and Hogg Cross Talk between LFA-1 and b1 Integrins 1445
the nonmigratory a4b1 is blocked. Another possibility is
that the enhanced migration by a5b1 is due to removal of
a restraint imposed by a4b1. The importance of strength
of adhesion in regulating cell migration is well docu-
mented (Huttenlocher et al., 1996; Palecek et al., 1997),
suggesting that firm adhesion by both a4b1 and a5b1 may
make conditions suboptimal for migration. Alternatively,
a4b1 may be involved in a more specific inhibition of a5b1
function, as has been described in the control of metallo-
proteinase expression in fibroblasts (Huhtala et al., 1995).
The promotion of migratory behavior by a5b1 through
loss of a4b1-binding activity is in keeping with its more
prominent role within the tissues after successful negotia-
tion of T cells across the endothelium (Miyake et al.,
1992). Therefore, a hierarchy of integrin activity may fea-
ture at this later stage of the adhesion cascade, with LFA-1
providing a link between a4b1 and a5b1.
The mechanism for LFA-1 downregulation of a4b1 was
explored in several ways. We first established that there
was no alteration in expression of either a4b1 or a5b1
during the experimental period (data not shown). Further-
more, confocal microscopy using mAbs specific for a4b1,
a5b1, and the b1-activation reporter mAb 15/7 indicated
that avid LFA-1 did not cause b1 integrin redistribution
on the T cell membrane (data not shown). In addition, al-
though stimulation of T cells with Mg21/EGTA induces
high affinity LFA-1 (Stewart et al., 1996), none of the
three stimulating protocols induced high affinity a4b1 or
a5b1. This implied that cross talk was not affecting high
affinity b1 integrins. Together, these findings suggested
Figure 9. Migration of T cells
on fibronectin is mediated
by a5b1 and promoted by
blocking a4b1 function. (A)
Migration of T cells on fi-
bronectin (10 mg/ml) is medi-
ated by a5b1 and enhanced
when  a4b1-mediated adhe-
sion to fibronectin is blocked
by the function-blocking a4
antibody mAb HP1/2. The
non–function-blocking a4 an-
tibody  mAb 7.2 had no effect.
(B) Migration of T cells
across membranes coated
with fibronectin at various
concentrations (0–50 mg/ml)
is dependent on a5b1. (C)
Addition of the a4-blocking
mAb HP1/2 increases migra-
tion above control mAb 52U.
This increased migration can
be blocked with the a5-
blocking mAb SAM-1 (5 mg/
ml). (D) Addition of the
LFA-1–activation mAb 24
increases migration above
control mAb 52U. This in-
creased migration can be
blocked with the a5-blocking
mAb SAM-1. The assay was
performed as described in
Materials and Methods, and
data are expressed as the to-
tal number of migrated cells.
Data represent the mean of
two readings from each well.
All assays were performed in
duplicate, with bars indicat-
ing the range of readings. Ex-
periments are representative
of four similar experiments.The Journal of Cell Biology, Volume 138, 1997 1446
that the b1 integrins had not undergone a detectable alter-
ation in affinity nor been redistributed or shed from the
cell surface, and that LFA-1 cross talk was targeting events
after ligand-binding. This result is in keeping with other
studies in which cross talk is ultimately dependent on the
presence of the b subunit cytoplasmic tail and steps subse-
quent to modulation of integrin affinity (Blystone et al.,
1994; Diáz-González et al., 1996).
It seemed possible that the cytoskeleton was a target of
LFA-1–mediated cross talk because both a4b1- and a5b1-
mediated adhesion were more sensitive to changes in actin
than was adhesion through LFA-1 (data not shown). How-
ever, for b1 integrin–mediated adhesion, the similarity in
cytochalasin D sensitivity of mAb 24–treated and un-
treated cells and the synergism between suboptimal doses
of cytochalasin D and mAb 24 in the inhibition of a4b1-
mediated binding to fibronectin (data not shown) sup-
ported the evidence that inhibition occurs upstream of cy-
toskeletal changes. These results implied that cross talk
affects an event in cell adhesion occurring after receptor
occupancy but before actin-mediated cytoskeletal changes,
and independent of both. In addition, protein kinase A,
associated with LFA-1 signaling and deadhesion (Rovere
et al., 1996), and protein kinase C, implicated in some pre-
vious cross talk studies (Blystone et al., 1994; Pacifici et al.,
1994), were not involved in this phenomenon (data not
shown).
LFA-1 cross talk was evident after several different ad-
hesion-inducing protocols, showing that the phenomenon
was not stimulus specific. The fact that cross talk was de-
pendent on ICAM-1 or mAb 24 indicated that occupancy
of LFA-1 was a prerequisite. Although the signaling path-
ways activated upon engagement of the b2 integrins are
not well understood, certain observations suggested that
cross talk did activate specific intracellular signaling path-
ways. Cross talk was not observed using the Jurkat T cell
line, which is known to have a defect in LFA-1 signaling
(Mobley et al., 1994). In addition, cross talk was induced
by mAb 24 Fab9 fragments but not by immobilized anti–
LFA-1 mAb, emphasizing the requirement for a mecha-
nism beyond LFA-1 clustering. For a5b1 on human fibro-
blasts, although clustering by mAbs of integrin on beads
induced phosphorylation and accumulation of p125 focal
adhesion kinase and tensin, ligand occupancy recruited
further cytoskeletal proteins to the signaling complex
(Miyamoto et al., 1995a,b). One speculation is that the tar-
gets of LFA-1 cross talk may be the proteins providing the
link between integrins and actin. However, several obser-
vations suggested that cross talk does not represent a sim-
ple sequestering of such intracellular proteins. First, integ-
rin activity operates in one direction only, so prolonged
activation of the b1 integrins using mAb TS2/16 does not
alter LFA-1 binding to ICAM-1. Second, LFA-1 predomi-
nantly affects the activity of a4b1, despite a sixfold abun-
dance of a4b1 over a5b1 (data not shown). Future work
will address the role of potential integrator molecules in
the cross talk phenomenon.
In summary, we describe inhibition of a4b1-binding ac-
tivity in T cells as a consequence of LFA-1 activation. A
speculation is that deadhesion of a4b1 from the apical sur-
face of the endothelium is required for LFA-1–mediated
migration across endothelium to proceed. Another obser-
vation is that T cell migration on fibronectin is mediated
by a5b1, and that this migration is enhanced by interfering
with a4b1 adhesion. LFA-1 might provide a link between
a4b1 and a5b1 by uncoupling the former in order to en-
hance migration by the latter. While the actual mechanism
by which cross talk is achieved is unclear, our findings im-
plicate a downstream signaling event brought about by
maintaining LFA-1 in a highly avid state.
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